Carlsberg Breweries terminates joint venture in Asia
August 01, 2003 07:50 ET
|
Orkla ASA
"We are terminating the joint venture because we are under the distinct impression that the character of the companies which Chang Beverages were to transfer to Carlsberg Asia does not correspond to...
Carlsberg Breweries opphever Joint Venturet i Asia
August 01, 2003 07:45 ET
|
Orkla ASA
"Vi opphever joint venturet, fordi vi er av den klare oppfattelse, at karakteren på de selskaper Chang Beverages skulle overføre til Carlsberg Asia ikke svarer til avtalen, og at verdien av disse ikke...
Monthly Statistics Stockholmsborsen July 2003
August 01, 2003 07:28 ET
|
Stockholmsborsen
STOCKHOLM, Sweden, August 01, 2003 (PRIMEZONE) -- Stockholmsborsen:
The turnover in number of traded stock options contracts for a single trading day reached an all time high in July (July 18) with...
Carlsberg Breweries Terminates Joint Venture in Asia -- Following the issue of stock exchange announcement, 'Discussions in Asia'
August 01, 2003 07:12 ET
|
Carlsberg A/S
VALBY, Denmark, Aug. 1, 2003 (PRIMEZONE) -- Carlsberg Breweries A/S (Other OTC:CABHF) and Khun Charoen/Chang Beverages Pte. Ltd. have not succeeded in resolving their disagreement regarding the...
Novartis Ophthalmics granted exclusive rights for development and commercialization of the first pharmaceutical treatment of myopia from Valley Forge Pharmaceuticals Inc.
August 01, 2003 06:00 ET
|
Novartis Pharma AG
Novartis Ophthalmics committed to advancing new therapy for myopia (nearsightedness) Basel, Switzerland and Irvine, Calif., USA, 8 January 2003 - Novartis Ophthalmics, the eye health unit of...
The Active Press Media Network Goes Live August 11th With Five New Press Release Repositories
August 01, 2003 06:00 ET
|
Active Press, LLC
LONE TREE, Colo., August 1, 2003 (PRIMEZONE) -- On Monday, August 11th, 2003, Active Press goes live with six new and unique websites, including five unique online press release repositories to round...
Celltech Group plc: US Food and Drug Administration Approves Zavesca -- First Oral Treatment Option for Type 1 Gaucher Disease
August 01, 2003 04:37 ET
|
Celltech Group plc
SLOUGH, U.K., August 1, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) and Actelion Ltd (SWX:ATLN) today announced that the US Food and Drug Administration (FDA) has approved Zavesca(R)...
Purported class action lawsuit against American Skandia dismissed
August 01, 2003 03:26 ET
|
Skandia
STOCKHOLM, Sweden, August 01, 2003 (PRIMEZONE) -- Skandia (Other OTC:SKNFF) (LSE:SDIAq):
On 31 July 2003, Senior Judge Milton Pollack of the United States District Court for the Southern District...
Telephone Conference on Observer Interim Report
August 01, 2003 03:09 ET
|
Observer
STOCKHOLM, Sweden, August 01, 2003 (PRIMEZONE) -- Observer AB (Other OTC: OBSEF) invites you to participate in a telephone conference on the Interim Report January -- June 2003, Tuesday August 5 at...
Head N.V . Conference Call
August 01, 2003 03:07 ET
|
Head N.V.
ROTTERDAM, Netherlands, August 01, 2003 (PRIMEZONE) -- Head's (NYSE:HED) conference call to discuss the second quarter results for 2003 will be held on Tuesday August 12, 2003 at 15:00 London time....
- August 12, 2024 03:00 ET Kier partners with Jack Parsons for International Youth Day
- August 12, 2024 02:00 ET Bedford Metals Obtains Satellite Survey Results on the Sheppard Lake Uranium Project, Northern Saskatchewan